Home / Forums / Q&A from Webinar: Model-informed Drug Repurposing – Applications for COVID-19 (May 14) / Which do we choose to carry forward? / Reply To: Which do we choose to carry forward?
Those docking studies are “directional,” and we need to take the compounds screened there forward into relevant cell lines. Caco2, Vero6, etc.